Medical cannabis for inflammatory bowel disease and IBS
UK patient guide separating IBD from IBS, medical cannabis evidence limits, symptom discussions, interactions and urgent-care boundaries.
Medical cannabis and palliative care
Practical UK guide for patients and carers on medical cannabis, palliative care, evidence limits, specialist review and safety boundaries.
Medical cannabis for chemotherapy nausea and appetite symptoms
UK patient guide to nabilone, chemotherapy nausea, appetite symptoms and medical cannabis boundaries, with oncology-team review kept central.
Medical cannabis for migraine and headache disorders
UK patient guide to migraine, headache disorders and medical cannabis evidence limits, assessment, medicines, interactions and safety.
Medical cannabis for neuropathic pain
UK patient guide to neuropathic pain, medical cannabis evidence limits, NICE guidance, previous treatments, records and safety screening.
Medical cannabis for arthritis and joint pain
What UK patients with arthritis or joint pain should know about medical cannabis evidence, NICE chronic pain guidance, records and safety.
Medical cannabis for fibromyalgia
Practical UK patient guide to fibromyalgia, NICE chronic pain guidance, private specialist assessment, records, safety and evidence limits.
Medical cannabis for ADHD
A practical UK guide to medical cannabis and ADHD: limited evidence, specialist assessment, stimulant and medicine interaction checks, anxiety, sleep, substance-use and mental-health risks.
Medical cannabis for depression and low mood
A cautious UK guide to medical cannabis, depression and low mood: evidence limits, specialist screening, urgent-help boundaries, medicine interactions and previous treatment history.
Treatment-resistant epilepsy and cannabis-based medicines
A cautious UK guide to treatment-resistant epilepsy, Epidyolex, NICE guidance, and the limits of unlicensed cannabis-based medicines.